These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25082945)

  • 1. Protection against experimental visceral leishmaniasis by immunostimulation with herbal drugs derived from Withania somnifera and Asparagus racemosus.
    Kaur S; Chauhan K; Sachdeva H
    J Med Microbiol; 2014 Oct; 63(Pt 10):1328-1338. PubMed ID: 25082945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the protective and immunomodulatory efficacy of Withania somnifera along with cisplatin against experimental visceral leishmaniasis.
    Sachdeva H; Sehgal R; Kaur S
    Parasitol Res; 2013 Jun; 112(6):2269-80. PubMed ID: 23519426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisplatin along with herbal drug treatment reduces the percentage of regulatory T cells and decreased the severity of experimental visceral leishmaniasis.
    Sachdeva H; Kaur S
    J Microbiol Immunol Infect; 2018 Aug; 51(4):435-445. PubMed ID: 28655574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Withania somnifera chemotype NMITLI 101R significantly increases the efficacy of antileishmanial drugs by generating strong IFN-γ and IL-12 mediated immune responses in Leishmania donovani infected hamsters.
    Tripathi CD; Kushawaha PK; Sangwan RS; Mandal C; Misra-Bhattacharya S; Dube A
    Phytomedicine; 2017 Jan; 24():87-95. PubMed ID: 28160866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asparagus racemosus ameliorates cisplatin induced toxicities and augments its antileishmanial activity by immunomodulation in vivo.
    Sachdeva H; Sehgal R; Kaur S
    Parasitol Int; 2014 Feb; 63(1):21-30. PubMed ID: 24103199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis.
    Thakur A; Kaur H; Kaur S
    Med Microbiol Immunol; 2015 Aug; 204(4):539-50. PubMed ID: 25432859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative evaluation of efficacy of chemotherapy, immunotherapy and immunochemotherapy in visceral leishmaniasis-an experimental study.
    Joshi J; Malla N; Kaur S
    Parasitol Int; 2014 Aug; 63(4):612-20. PubMed ID: 24747611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Withania somnifera chemotypes NMITLI - 101R, 118R and Withaferin A against experimental visceral leishmaniasis.
    Tripathi CD; Gupta R; Kushawaha PK; Mandal C; Misra Bhattacharya S; Dube A
    Parasite Immunol; 2014 Jun; 36(6):253-65. PubMed ID: 24830833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapeutic Potential of Eugenol Emulsion in Experimental Visceral Leishmaniasis.
    Islamuddin M; Chouhan G; Want MY; Ozbak HA; Hemeg HA; Afrin F
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005011. PubMed ID: 27776125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice.
    Thakur A; Kaur H; Kaur S
    Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinospora cordifolia as a protective and immunomodulatory agent in combination with cisplatin against murine visceral leishmaniasis.
    Sachdeva H; Sehgal R; Kaur S
    Exp Parasitol; 2014 Feb; 137():53-65. PubMed ID: 24370645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the protective efficacy of second-generation vaccine along with standard antileishmanial drug in Leishmania donovani infected BALB/c mice.
    Joshi J; Kaur S
    Parasitology; 2014 Apr; 141(4):554-62. PubMed ID: 24618257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Live Attenuated Leishmania donovani Centrin Knock Out Parasites Generate Non-inferior Protective Immune Response in Aged Mice against Visceral Leishmaniasis.
    Bhattacharya P; Dey R; Dagur PK; Joshi AB; Ismail N; Gannavaram S; Debrabant A; Akue AD; KuKuruga MA; Selvapandiyan A; McCoy JP; Nakhasi HL
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004963. PubMed ID: 27580076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic efficacy of artemisinin-loaded nanoparticles in experimental visceral leishmaniasis.
    Want MY; Islamuddin M; Chouhan G; Ozbak HA; Hemeg HA; Dasgupta AK; Chattopadhyay AP; Afrin F
    Colloids Surf B Biointerfaces; 2015 Jun; 130():215-21. PubMed ID: 25936561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 115 kDa serine protease confers sustained protection to visceral leishmaniasis caused by Leishmania donovani via IFN-γ induced down-regulation of TNF-α mediated MMP-9 activity.
    Choudhury R; Das P; De T; Chakraborti T
    Immunobiology; 2013 Jan; 218(1):114-26. PubMed ID: 22440312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis.
    Sharma M; Sehgal R; Kaur S
    PLoS Negl Trop Dis; 2012; 6(5):e1629. PubMed ID: 22563510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis.
    Das P; Paik D; Naskar K; Chakraborti T
    Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete protection against experimental visceral leishmaniasis with complete soluble antigen from attenuated Leishmania donovani promastigotes involves Th1-immunity and down-regulation of IL-10.
    Bhaumik SK; Naskar K; De T
    Eur J Immunol; 2009 Aug; 39(8):2146-60. PubMed ID: 19593771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The leishmanicidal activity of oleuropein is selectively regulated through inflammation- and oxidative stress-related genes.
    Kyriazis ID; Koutsoni OS; Aligiannis N; Karampetsou K; Skaltsounis AL; Dotsika E
    Parasit Vectors; 2016 Aug; 9(1):441. PubMed ID: 27501956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Potent ITK/BTK Inhibitor Ibrutinib Is Effective for the Treatment of Experimental Visceral Leishmaniasis Caused by Leishmania donovani.
    Varikuti S; Volpedo G; Saljoughian N; Hamza OM; Halsey G; Ryan NM; Sedmak BE; Seidler GR; Papenfuss TL; Oghumu S; Satoskar AR
    J Infect Dis; 2019 Jan; 219(4):599-608. PubMed ID: 30239895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.